Diversify Advisory Services LLC Purchases New Position in Elevai Labs, Inc. (NASDAQ:ELAB)

Diversify Advisory Services LLC acquired a new position in Elevai Labs, Inc. (NASDAQ:ELABFree Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 52,500 shares of the company’s stock, valued at approximately $36,000. Diversify Advisory Services LLC owned about 0.30% of Elevai Labs as of its most recent filing with the Securities and Exchange Commission (SEC).

Elevai Labs Trading Up 0.5 %

Elevai Labs stock opened at $0.58 on Monday. Elevai Labs, Inc. has a one year low of $0.57 and a one year high of $4.24. The company’s fifty day moving average price is $0.64 and its two-hundred day moving average price is $0.83. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.57 and a quick ratio of 1.80. The company has a market capitalization of $10.86 million and a price-to-earnings ratio of -1.55.

Elevai Labs (NASDAQ:ELABGet Free Report) last released its quarterly earnings results on Wednesday, May 15th. The company reported ($0.08) earnings per share (EPS) for the quarter. Elevai Labs had a negative return on equity of 225.32% and a negative net margin of 211.25%. The company had revenue of $0.62 million for the quarter.

Elevai Labs Profile

(Free Report)

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.

See Also

Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.